Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Dafopoulos, Konstantinos ^a   Venetis, Christos ^a   Messini, Christina I ^a   Pournaras, Spyros ^a   Anifandis, George ^a   Garas, Antonios ^a   Messinis, Ioannis E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; FOLLITROPIN; GESTAGEN; INHIBIN; PROTEIN SUBUNIT;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; LUTEAL PHASE; OVARY POLYCYSTIC DISEASE; BLOOD; CLINICAL TRIAL; DRUG EFFECT; METABOLISM; OVARY; SECRETION; TIME;

ADULT; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; LUTEINIZING HORMONE; OVARY; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; PROGESTINS; PROTEIN SUBUNITS; TIME FACTORS; YOUNG ADULT;

EID: 79955448332     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-59     Document Type: Article

References (23)

1. Lockwood GM, Muttukrishna S, Groome NP, Matthews DR, Ledger WL. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 1998, 183:1730-1735.
2. Anderson RA, Groome NP, Baird DT. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin Endocrinol 1998, 48:577-584.
3. Pigny P, Cortet-Rudelli C, Decanter C, Deroubaix D, Soudan B, Duhamel A, Dewailly D. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism. Fertil Steril 2000, 73:972-977. 10.1016/S0015-0282(00)00421-0, 10785223.
4. Laven JS, Imani B, Eijkemans MJ, de Jong FH, Fauser BC. Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility. Hum Reprod 2001, 16:1359-1364. 10.1093/humrep/16.7.1359, 11425813.
5. Welt CK, Taylor AE, Martin KA, Hall JE. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone. J Clin Endocrinol Metab 2002, 87:5559-5565. 10.1210/jc.2002-020546, 12466353.
6. Cortet-Rudelli C, Pigny P, Decanter C, Leroy M, Maunoury-Lefebvre C, Thomas-Desrousseaux P, Dewailly D. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Fertil Steril 2002, 77:281-287. 10.1016/S0015-0282(01)02968-5, 11821084.
7. Tsigkou A, Luisi S, De Leo V, Patton L, Gambineri A, Reis FM, Pasquali R, Petraglia F. High serum concentration of total inhibin in polycystic ovary syndrome. Fertil Steril 2008, 90:1859-1863. 10.1016/j.fertnstert.2007.08.082, 18423626.
8. Wachs DS, Coffler MS, Malcom PJ, Shimasaki S, Chang RJ. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93:1827-1833. 10.1210/jc.2007-2664, 2386684, 18285408.
9. Rosencrantz MA, Wachs DS, Coffler MS, Malcom PJ, Donohue M, Chang RJ. Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women. Hum Reprod 2010, 25:198-203. 10.1093/humrep/dep373, 2794669, 19850592.
10. Segal S, Elmadjian M, Takeshige T, Karp S, Mercado R, Rivnay B. Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance. Reprod Biomed Online 2010, 20:675-680. 10.1016/j.rbmo.2010.02.006, 20231113.
11. Welt CK, Smith ZA, Pauler DK, Hall JE. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocrinol Metab 2001, 86:2531-2537. 10.1210/jc.86.6.2531, 11397851.
12. Wachs DS, Coffler MS, Malcom PJ, Chang RJ. Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women. J Clin Endocrinol Metab 2006, 91:2920-2925. 10.1210/jc.2006-0442, 16720653.
13. Buckler HM, Bangah M, Healy DL, Burger HG. Vaginal progesterone administration in physiological doses normalizes raised luteinizing hormone levels in patients with polycystic ovarian syndrome. Gynecol Endocrinol 1992, 6:275-82. 10.3109/09513599209024991, 1492584.
14. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19:41-47. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group.
15. Messinis IE, Lolis D, Papadopoulos L, Tsahalina T, Papanikolaou N, Seferiadis K, Templeton AA. Effect of varying concentrations of follicle stimulating hormone on the production of gonadotrophin surge attenuating factor (GnSAF) in women. Clin Endocrinol 1993, 39:45-50.
16. Messinis IE, Lolis D, Zikopoulos K, Tsahalina E, Seferiadis K, Templeton AA. Effect of an increase in FSH on the production of gonadotrophin- surge-attenuating factor in women. J Reprod Fertil 1994, 101:689-695. 10.1530/jrf.0.1010689, 7966027.
17. Lolis DE, Tsolas O, Messinis IE. The follicle-stimulating hormone threshold level for follicle maturation in superovulated cycles. Fertil Steril 1995, 63:1272-1277.
18. Lenton EA, Landgren BM, Sexton L. Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase. Br J Obstet Gynaecol 1984, 91:685-9. 10.1111/j.1471-0528.1984.tb04831.x, 6743610.
19. Dafopoulos K, Venetis C, Pournaras S, Kallitsaris A, Messinis IE. Ovarian control of pituitary sensitivity of luteinizing hormone secretion to gonadotropin-releasing hormone in women with the polycystic ovary syndrome. Fertil Steril 2009, 92:1378-1380. 10.1016/j.fertnstert.2009.04.033, 19467538.
20. Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin A by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab 2001, 86:330-336. 10.1210/jc.86.1.330, 11232020.
21. Elting MW, Kwee J, Schats R, Rekers-Mombarg LT, Schoemaker J. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries. J Clin Endocrinol Metab 2001, 86:1589-1595. 10.1210/jc.86.4.1589, 11297588.
22. Burger HG, Groome NP, Robertson DM. Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. J Clin Endocrinol Metab 1998, 83:4167-4169. 10.1210/jc.83.11.4167, 9814508.
23. Cortet-Rudelli C, Pigny P, Decanter C, Leroy M, Maunoury-Lefebvre C, Thomas-Desrousseaux P, Dewailly D. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Fertil Steril 2002, 77:281-287. 10.1016/S0015-0282(01)02968-5, 11821084.